Cooley has advised Electra Therapeutics, and Gibson Dunn has advised Nextech Ventures and EQT Life Sciences. Electra Therapeutics, a clinical-stage biotechnology company focused on developing therapies...
Electra Therapeutics Secures $183 Million Series C Funding for Immunology and Cancer Therapies
Bristol Myers Squibb’s $4.1 Billion Acquisition of Turning Point Therapeutics
Cooley advised Turning Point Therapeutics, while Kirkland & Ellis advised Bristol Myers Squibb on the deal. Bristol Myers Squibb (NYSE:BMY), a global biopharmaceutical company, announced its...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...



























